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Turmeric (Curcuma longa) belongs to the family Zingiberaceae and it has been traditionally used for centuries in 
Asian cuisine. India is the largest producer, consumer and exporter of turmeric. Its dried and ground tuber is used 
worldwide as a spice (the most famous spice which contains turmeric is curry) and as an additive for a variety of 
products that require medically acceptable intense yellow color. The most important part of the turmeric tuber is a 
group of bioflavonoids, i.e. curcumins (curcumin (77%), bisdemethoxycurcumin and demethoxycurcumin). The most 
common method for the isolation of curcumin is extraction with organic solvents, usually ethanol, by using Soxhlet, 
ultrasonic and microwave extraction, and more recently, due to increased use in the food industry (food supplements), 
triacylglycerol. Curcumin has significant anti-inflammatory, antioxidant, chemoprotective, anticancer, and 
gastroprotective properties. It affects the neurosystem and it is one of the most investigated bioflavonoids. The aim of 
this paper is to present the dietary and health benefits of turmeric and curcumin for both humans and animals. 
 




Turmeric (curcuma) - Curcuma longa L. 
(Zingiberaceae) is a perennial plant native to 
Southeast Asia; it has been used since ancient 
times as a spice, in medicine, and for coloring and 
flavoring food. In addition to Curcuma longa L., 
the genus turmeric contains about 30 other 
species. The name Curcuma is derived from the 
Arabic word "turmeric" which means yellow. In 
Sanskrit, turmeric has 55 different names 
associated with its religious and medical use 
(Ravindran, 2007). The varieties Allepey and 
Madras are mostly cultivated in India (82%), and 
its yield was around 720,000 tons in 2015/2016. 
The part of turmeric used in food and medicine is 
the rhizome. The rhizome is harvested, cleaned, 
and boiled until it becomes soft, and then dried in 
the sun in a 5-7 cm thick layer for about 2 weeks. 
The yield is 10-30%, depending on the variety and 
the cultivation area (Kandiannan et al., 2008). 
Dried product is milled and marketed. Products 
prepared in this way are used in diets as spices, 
and as the basic raw material for the production of 
the bioflavonoid curcumin. Curcumin is used as 
an additive (E100), and its main purpose is 
coloring products yellow and up to red, depending 
on the pH of the product. Curcumin is one of the 
most researched bioflavonoids today and a 
number of studies have confirmed its antioxidant, 
anti-inflammatory, anti-cancer, chemoprotective, 
gastroprotective, and many other health 
properties. Studies have shown that it is not toxic, 
even at doses up to 12 g / day, and it is tolerated 
very well by the human body (Basnet et al., 
2011). Most studies have shown that the 
biological effect of curcumin in large part comes 
from its ability to directly bind to different 
proteins (cyclooxygenase, lipoxygenase) or to 
modulate the intracellular redox state (Srivastava 
et al., 2011). 
The shortfall of this bioflavonoid is its relatively 
poor absorption, and it is therefore necessary to 
conjugate it. Recent research studies considered 
its adoption in the form of nanoparticles. 
 
Preparation of curcumin and its use as a food 
additive 
 
Curcuma longa L. contains about 2-9% of 
curcuminoids. The most important of those are 
curcumin (77%), dimethoxy-curcumin (17%), and 
bis-demethoxy-curcumin (3%). These three 
compounds differ in the substitution of methoxy 









Fig. 1. Composition of curcumin 
 
 
Curcumin (E,E) -1,7-bis (4-hydroxy-3-methoxyphenyl) 
hepta-1,6-diene-3,5-dione) is extracted from the tubers of 
a dried and milled turmeric by using a suitable solvent. 
The oily resin is obtained after the extraction and removal 
of the solvent, and contains 25-35% of the pigment, 
along with the volatile oils and resin extracts. After the 
purification of the resin, approximately 90% of the 
pigment is obtained. The solvents which can be used for 
the extraction are: isopropanol, ethyl acetate, acetone, and 
ethanol. Curcumin is soluble in oils, insoluble in water at 
acidic and neutral pH, but soluble in alkaline conditions. 
The color of curcumin highly depends on the pH, at pH 
2.5 to 7.0, it has an intense yellow color, and above pH 
7.0 it is red. 
For nutritional purposes, it is primarily used as an 
additive for coloring products. It is used in all sectors of 
the food industry, in the amount of 5-500 mg / kg, 
depending on the food category. 
As an additive, curcumin is stable during thermal 
treatment and in dry food. It is relatively inert to reactions 
with other ingredients (may form salts with phthalates 
and citrates), and it is inert in the reactions with 
phosphates, chlorides, and bicarbonates (Stankovic, 
2004). 
Besides being used for food coloring, curcumin shows 
significant antioxidant properties and it prevents lipid 
peroxidation to a significant extent. The antioxidant 
properties are the result of the double carboxyl groups 
along with hydroxyl groups (Stankovic, 2004). Curcumin 
binds free radicals, and it becomes a short-lived, non-
reactive free radical, and as such does not represent a 
health hazard (Majeed et al., 2000). 
 
The absorption and metabolic pathway of curcumin 
 
A number of previous studies have shown that curcumins 
exhibit poor bioavailability in the human body when 
administered orally. It is due to their rapid degradation 
and poor absorption in the gastrointestinal tract, which 
results in low plasma concentrations and a very 
lowdistribution in tissues. 
Curcumin in the body is converted into dihydrocurcumin 
(DHC), tetrahydrocurcumin (THC), hexahydrocurcumin 
(HHC), and octahydrocurcumin with reductase activity, 
and thoseare further decomposed by the action of β-
glucuronidase to dihydrocurcumin-glucuronide and 
tetrahydrocurcumin -glucuronide (Pan et al., 1999). Poor 
absorption can be seen in the example of a clinical trial in 
which the oral intake of 3.6 g of standardized extract per 
day showed that one hour after intake the plasma 
concentration was only 11.1 mmol / L (Sharma et al, 
2004). Due to this limitation, different formulations of 
curcumin were tested in order to maximize its availability 
and activity. In addition to oral intake, subcutaneous 
entry was investigated and has proven effective in 
keeping curcumin in tissues for a longer period (Shahani 
et al., 2010). Intravenous intake in the form of 
nanoparticles has been proven effective for the treatment 
of tumors in animals. (Kim et al., 2011) and Wang et al., 
2008, Shi et al., 2011, showed that curcumin in  
liposomal form is effective in enhancing the effect of 
chemotherapy. The use of curcumin on the skin has 
proven to be very effective in treating certain types of 
psoriasis, wound healing, candidiasis, etc. (Prasad et al., 
2014). Recent research has shown that oral intake in the 
form of nanoparticles increases the availability of 
curcumin 5-6 times in comparison to the standardized 
extract, due to increased water solubility it dissolves 
better in the digestive system and itsdegradation is longer 
(Xie et al., 2011). Nanoparticles are also safe, non-toxic, 
biodegradable, do not cause allergies in the body, and can 
be designed to be time releasing (Sankar et al., 2016). 
The combination of curcumin with piperine, liposomal, 
and phospholipid complexes also increases 
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bioavailability (Prasad et al., 2014). A hydrophilic carrier 
dispersed curcuminoid formula exhibits 46 times the 
bioavailability of the standard purified 95 percent 
curcuminoid preparation (Douglass and Clauatre, 2015). 
 
Antioxidant properties of curcumin 
 
Curcumin shows very significant antioxidant properties 
as a food additive. In the presence of curcumin, the 
oxidation of linoleic acid is very slow, and the 
antioxidant effect is about 80% (Jayaprakasha et al., 
2006) when used as a dietary supplement. It works in a 
way that binds free radicals and it also donates a 
hydrogen atom (responsible for its antioxidant properties) 
(Wei et al., 2006). Curcumin has a property of donating 
electrons in order to neutralize free radicals by creating 
stable products, and thus breaking a chain reaction of 
creating free radicals in a living organism. Curcumins’ 
ability of capturing hydrogen peroxide is higher than that 
of the commercial antioxidants (BHA, BHT, vitamin E) 
at the same concentration (20 mM) (Ak and Gülcin, 
2008). 
Curcumin shows a significant effect on hepatic oxidative 
stress in diets with high cholesterol by reducing 
antioxidative liver enzymes (catalase, glutathione 
peroxidase, and superoxide dismutase), it also reduces 
TNF-α (tumor necrosis factor alpha), serum IL-6 
(interleukin 6), liver enzymes, and heart disease enzyme 
markers. Supplementation of curcumin in patients with 
hyperlipidemia can reduce cardiovascular problems 
(Hussein et al., 2016). 
The study on oxidative stress and the loss of vitamins C 
and E during sleep in an area with little or no gravity 
(astronauts) showed that curcumin reduces the loss of 
these vitamins (Rai et al., 2010). 
Curcumin prevents oxidation and lipid modification of 
low density lipoproteins, and as a consequence, the 
inhibition of prostacyclin (PGI2), which contributes to the 
formation of thrombosis and arteriosclerosis, and thus 





Curcumin reduces the response of specific proteins - 
cytokines that occur in the processes of inflammation, 
such as TNF-α, interleukins (IL-1, IL-2, IL-6, IL-8, IL-
12),  chemokines, through the inhibitory effect on NF-κB 
(cellular factor kappa B), and even directly binding to 
TNF-α (Anthwal al., 2014). A series of studies on 
animals have shown that the dose of 100-200 mg per kg 
of body weight indicates good anti-inflammatory activity 
(Kohli et al., 2004). Curcumin reduces the inflammation 
associated with colitis by significantly reducing the 
activity of myeloperoxidase and TNF-α (Basnet et al., 
2011). Liu et al. (2015) have shown that curcumin 
reduces the pathological changes in the lungs and the 
accumulation of inflammatory cells in the airways of 
asthmatic mice by downregulating  the expression of pro-
inflammatory cytokines with the  activation of the Nrf2 / 
HO-1 (nuclear factor erythroid 2-related factor / heme 
oxygenase-1) signaling pathway.  Nuclear factor 
erythroid 2-related factor (Nrf2) is a cytoprotective factor 
which regulates the expression of gene coding for anti-
oxidant, anti-inflammatory, and detoxifying proteins. 
Pancreatitis is another inflammatory process associated 
with the secretion of NF-κB cytokines. Curcumin 
significantly reduces the activation of this cytokine and 
AP-1 (activator protein 1), and reduces the mRNA 
induction of iNOS (nitric oxide synthase), TNF-α and IL-
6 cytokines in the pancreas (Gulcubuk et al., 2013). 
Studies on the effects of curcumin on allergies have 
shown that curcumin inhibits the NF-κB in the airway, 
together with the transcription factor GATA3, reduces 
IgE in serum, and inhibits the Notch1-GTA3 signaling 




The transcription factor NF-κB has the main role in the 
creation of tumors and inflammation, and the goal of 
most pharmaceutical and entomological preparations is to 
reduce its hyper productivity. Curcumin is a natural 
product which reacts with various compounds in the 
downstream of the NF-κB pathway. Curcumin blocks 
IKK activation, phosphorylation, and the degradation of 
IĸBα (Kastori et al., 2015, Fiala, 2015). A large number 
of curcumin analogues were investigated in order to 
improve its efficiency in blocking NF-ĸB, including the 
latest analogs called BAT (Katsori et al., 2011, Kasinski 
et al. 2008). Katsori et al. (2015) have shown that the 
curcumin analog BAT3 selectively inhibits NF-ĸB 
dependent gene expression by binding to chromatin 
DNA in the laboratory. Curcumin inhibits the growth of 
androgen-independent prostate cancer cells through 
ERK1/2- and SAPK/JNK-mediated inhibition of p65, 
followed by the reducing expression of MUC1-C protein. 
The MUC1-C is a protein that has a markedly increased 
expression in prostate tumors (Li et al., 2015). In 
combination with α-tomation, It is also effective in 
inhibiting PC3 prostate tumor cells by inhibiting the NF-
ĸB and decreasing the expression of the Bcl-2 gene 
(Huang et al., 2015). Khosropanah et al. (2016) 
formulated curcumin nanoparticles to increase its 
bioavailability and to study the effect on breast cancer 
cells (MDA-MB 231), i.e. cytotoxicity on tumor cells. 
More than 50% of the tumor cells died within 48 hours 
after the administration of curcumin. The dosage of nano-
formulated curcumin in this study was effective in half 
the dosage of the regular preparation of curcumin. 
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Theresearch on gastrointestinal tract tumors has shown 
that curcumin in combination with quercetin (enhances 
the absorption of curcumin) inhibits phosphorylase AKT 
and ERK and induces apoptosis through a mitochondrial 
pathway (Zhang et al., 2015). Sridhar et al. (2014) 
researched the effect of the nanoparticles on a breast 
tumor culture (MCF7) and a lungs culture (A459), and in 
both cases the nanoparticles composed of 1% aloe vera 
gel and 5% curcumin showed 15% higher cytotoxicity 
than nanoparticles with conventional antitumor drugs. 
Some of the most important anticancer activities of 
curcumin are summarized in Table 1. 
 
Table 1. The anticancer activities of curcumin (Bar-
Sela et al., 2010) 
 
Immunologic modulation  
Radiosensitization and radioprotection 
Chemopreventive, chemotherapeutic 
Inhibition of angiogenesis and metastasis 
Chemosensitizing activity 
Inhibition of NF-ĸB 
Downstream of NF-ĸB: Inhibition of cyclin D1 
Downstream of NF-ĸB: Inhibition of COX-2 
Downstream of NF-ĸB: Suppression of Bcl-2 and Bcl-XL 
Inhibition of cytokines inhibits the pro-survival kinase Akt 
Induction of phase II enzymes 
Modulation of growth factors and their signaling pathway 
Inhibition of STAT3 activation  
 
 
Antimutagenic, antimicrobial and gastroprotective 
effect 
 
Heterocyclic amines are formed during the 
processing of protein rich food at high temperatures 
and are known for their carcinogenic effect. The 
study was conducted in order to explain the 
antimutagenic properties of curcumin, and it showed 
that all three curcumins are very effective in 
preventing S9 mediated mutagenicity (> 80%) at a 
concentration of 200 µg. Unsaturation in the side 
chain, a methoxy group on the benzene ring, and a 
central b-diketone moiety in the curcumin molecule 
are responsible for its high antimutagenic potential 
(Shishu and Kaur, 2008). 
Curcumin shows significant antimicrobial properties. 
Studies carried out on  G + (B. cereus and S. aureus) 
and G - (E. coli and Y. enterocolitica) bacteria have 
shown that curcumin and curcumin β glycoside at the 
concentration of 0.2-0.7 µM, have a 100% inhibitory 
effect on the tested G + bacteria and Y. 
enterocolitica, while they have a slightly lower effect 
on the E. coli (70%) (Parvathy et al., 2009). Wang et 
al. (2016) examined the effect of curcumin on the 
development of pneumonia in mice caused by 
Staphylococcus aureus and showed that curcumin 
effectively blocks the development of pneumonia by 
binding to α-hemolysin (virulence factor and toxin 
secreted by S. aureus). 
Curcumin is highly effective in suppressing 
Helicobacter pylori in the stomach. Research has 
shown that curcumin inhibits the shikimate path 
required for the synthesis of the bacteria aromatic 
ring, and therefore its growth. The histological 
analysis in the same study showed that curcumin also 
restores damaged cell walls of the stomach caused by 




In the past 30 years, numerous studies of curcumins’ 
effect on cell tissues and animals, as well as clinical 
studies, have shown its multiple medical benefits 
(more than 10,000 published papers in the last 10 
years). Despite its very poor bioavailability and 
absorption in the body tissues, curcumin has been 
recognized as an important therapeutic natural 
product. The highest medical value of curcumin is its 
strong antioxidant effect and its binding to 
inflammatory transcription factors as to precursors 
whether chronic diseases or tumors. Despite the large 
number of papers, a very small number of clinical 
trials were conducted specifically on humans in order 
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